High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI

Efficacy Of High-Dose Rosuvastatin Preloading Before Primary Percutaneous Coronary Intervention In Patients Suffering From St-Elevation Myocardial Infarction

To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days

Inclusion Criteria:

• Age 18-75 years Patients undergoing primary angiography

Exclusion Criteria:

• Hemodynamically unstable patients. History or clinical evidence of any co-morbidities. Taking any medications regularly even statins.